As of 2025-01-20, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (9.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.21 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -543.4%.
The range of the Relative Valuation is (8.15) - (9.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 22.1x | 17.6x |
| Forward P/E multiples | 18.5x - 35.9x | 27.0x |
| Fair Price | (8.15) - (9.74) | (9.80) |
| Upside | -468.6% - -540.8% | -543.4% |
| Date | P/E |
| 2025-01-17 | -5.15 |
| 2025-01-16 | -5.13 |
| 2025-01-15 | -5.02 |
| 2025-01-14 | -5.09 |
| 2025-01-13 | -5.18 |
| 2025-01-10 | -5.31 |
| 2025-01-08 | -4.93 |
| 2025-01-07 | -4.93 |
| 2025-01-06 | -4.88 |
| 2025-01-03 | -4.97 |
| 2025-01-02 | -5.00 |
| 2024-12-31 | -5.00 |
| 2024-12-30 | -4.88 |
| 2024-12-27 | -5.18 |
| 2024-12-26 | -5.27 |
| 2024-12-24 | -5.22 |
| 2024-12-23 | -5.09 |
| 2024-12-20 | -4.97 |
| 2024-12-19 | -4.94 |
| 2024-12-18 | -4.90 |
| 2024-12-17 | -5.59 |
| 2024-12-16 | -5.29 |
| 2024-12-13 | -5.11 |
| 2024-12-12 | -5.79 |
| 2024-12-11 | -6.11 |
| 2024-12-10 | -6.90 |
| 2024-12-09 | -8.70 |
| 2024-12-06 | -7.90 |
| 2024-12-05 | -7.58 |
| 2024-12-04 | -8.31 |
| 2024-12-03 | -7.38 |
| 2024-12-02 | -7.04 |
| 2024-11-29 | -6.36 |
| 2024-11-27 | -5.77 |
| 2024-11-26 | -5.84 |
| 2024-11-25 | -5.84 |
| 2024-11-22 | -5.72 |
| 2024-11-21 | -5.61 |
| 2024-11-20 | -5.47 |
| 2024-11-19 | -5.47 |
| 2024-11-18 | -4.88 |
| 2024-11-15 | -4.81 |
| 2024-11-14 | -4.77 |
| 2024-11-13 | -5.06 |
| 2024-11-12 | -5.52 |
| 2024-11-11 | -5.72 |
| 2024-11-08 | -5.18 |
| 2024-11-07 | -4.79 |
| 2024-11-06 | -5.02 |
| 2024-11-05 | -4.81 |